The Use of Cyclodextrin Inclusion Complexes to Increase the Solubility and Pharmacokinetic Profile of Albendazole
2023
Yili Ding | Zhiyuan Zhang | Charles Ding | Shufeng Xu | Zhe Xu
Albendazole is the preferred deworming drug and has strong insecticidal effects on human and animal helminth parasites, showing remarkable activity against hepatocellular carcinoma and colorectal cancer cells. However, it is classified as being in class II in the Biopharmaceutics Classification System due to its poor water solubility (0.2 mg/L) and high permeability, which make the clinical application of albendazole impractical. Through complexation with methyl-&beta:-cyclodextrin, as the best result so far, albendazole&rsquo:s water solubility was increased by 150,000 times, and albendazole could be 90% released during the first 10 min. In an in vivo pharmacokinetic study, the Cmax and Tmax of the active metabolized sulfoxide were changed from 2.81 µ:g/mL at 3 h to 10.2 µ:g/mL at 6 h and the AUC0&ndash:48 was increased from 50.72 h⁎:&mu:g/mL to 119.95 h⁎:&mu:g/mL, indicating that the inclusion complex obtained can be used as a new oral therapeutic anti-anthelmintic and anti-tumor agent formulation.
显示更多 [+] 显示较少 [-]